Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q73197599)
Watch
English
Mechanisms in failure of infliximab for Crohn's disease
scientific article published on 01 October 2000
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11081530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
title
Mechanisms in failure of infliximab for Crohn's disease
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11081530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
main subject
Crohn's disease
1 reference
based on heuristic
inferred from title
author name string
S Nikolaus
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11081530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
A Raedler
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11081530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
T Kühbacker
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11081530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
N Sfikas
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11081530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
U R Fölsch
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11081530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
S Schreiber
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11081530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
language of work or name
English
0 references
publication date
1 October 2000
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11081530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11081530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
volume
356
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11081530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
issue
9240
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11081530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
page(s)
1475-1479
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11081530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
cites work
Disease activity courses in a regional cohort of Crohn's disease patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Frequency of glucocorticoid resistance and dependency in Crohn's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A controlled double blind study of azathioprine in the management of Crohn's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
NF-kappa B subunit-specific regulation of the interleukin-8 promoter
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The NF-kappa B and I kappa B proteins: new discoveries and insights
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An interleukin-4-induced transcription factor: IL-4 Stat
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Activation of nuclear factor kappa B inflammatory bowel disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tumour necrosis factor alpha in stool as a marker of intestinal inflammation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kappaB activation in mouse colonocytes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of interleukin-1-stimulated NF-kappaB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902871-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(00)02871-3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11081530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
PubMed publication ID
11081530
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11081530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit